PRKAA2 and cancer: AMPK, and specifically the α1 isoform that is amplified in some cancers, is selectively activated in the cell nucleus by genotoxic treatments, providing protection against cell death induced by such treatments, at least in part by up-regulating expression of p21CIP1 [7].